Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alten Calsoft chalks cloud computing route to spur growth from health informatics & LIMS

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
CalSoft Labs uses cloud based solutions and big data analytics for electronic data capture, analysis, preservation, and retrieval, along with secure & integrated infrastructure.

Alten Calsoft Labs has drawn up a three pronged growth plan to tap the burgeoning opportunities in health informatics and Laboratory Information Management Systems (LIMS)

Indian business opportunities in the pharma, biotech, and healthcare space are also on radar of the company. The company has chartered three initiatives to focus on solutions driven by cloud computing, mobile based technologies and big data analytics.

With the need to embed Good Lab Practices (GLP) in the entire Laboratory Information Management Systems, the company uses cloud based solutions and big data analytics for electronic data capture, analysis, preservation, and retrieval, along with secure & integrated infrastructure.

Cloud based solutions will enable Indian companies to adopt information technology solutions for GLP with lower upfront investment. Our cloud based approach will help companies to integrate different business processes related to GLP quickly and efficiently, Somenath Nag, director – ISV and Enterprise Solutions, Alten Calsoft Labs told Pharmabiz.

With mobile device based solutions would enable capture electronic data as and where it is produced to improve efficiency and reduce data loss. The cloud based big data analytics solutions will enhance storage, retrieval and analysis of data to generate real-time/results as and when required.

In India, the company has been operating for the past two decades. Predominantly, during this period, it utilized Indian talent pool to serve its international customers. Backed by the comprehensive experience accumulated through servicing international life sciences & healthcare customers, Alten Calsoft Labs devised its Indian market strategy to bring the global best practices to Indian market.

There are several players in the space offering similar solutions. ”Our key differentiators are the ability to provide custom solutions based on modern technologies that is fit for our customers business rather than providing a generic pre-built solution. We have the experience in working with leading life sciences and healthcare companies across the globe that enables us to bring the best practices to Indian market. Further, our team has the capability to  build ‘product-grade’ solutions based on our rich experience of working with leading global product companies”, said Nag,

“We work with leading product companies in health informatics, medical devices and life sciences across the globe, but will not be able to indicate details due to business confidentiality norms”, he added.

The revenue drivers for the company at this point of time is health informatics, but we expect to see faster revenue growth in medical devices or life sciences segments also, he said.

For Alten Calsoft, international business constitute 98 percent. Despite such a large component of orders from abroad, the company stated that it has not experienced any negative impact on its growth in healthcare & life Sciences segments during the global economic slowdown.  On the contrary there has been a steady growth both from existing customers’ and in acquiring new customers.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!